
SunLink Health (SSY) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
7.3M
Gross Profit
2.7M
37.14%
Operating Income
-683.0K
-9.33%
Net Income
-671.0K
-9.16%
EPS (Diluted)
$-0.10
Balance Sheet Metrics
Total Assets
17.5M
Total Liabilities
4.1M
Shareholders Equity
13.4M
Debt to Equity
0.30
Cash Flow Metrics
Free Cash Flow
-654.0K
Revenue & Profitability Trend
SunLink Health Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 32.4M | 34.3M | 41.3M | 40.7M | 47.8M |
Cost of Goods Sold | 19.5M | 19.8M | 21.2M | 19.1M | 23.2M |
Gross Profit | 12.9M | 14.5M | 20.1M | 21.6M | 24.7M |
Gross Margin % | 39.8% | 42.2% | 48.6% | 53.1% | 51.6% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 10.9M | 10.5M | 19.6M | 14.4M | 20.2M |
Other Operating Expenses | 3.0M | 2.6M | 4.3M | 4.0M | 3.4M |
Total Operating Expenses | 13.9M | 13.1M | 23.9M | 18.4M | 23.5M |
Operating Income | -2.4M | 74.0K | -5.3M | 1.9M | -329.0K |
Operating Margin % | -7.4% | 0.2% | -12.9% | 4.6% | -0.7% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | - | - | - | - | 29.0K |
Other Non-Operating Income | 2.0K | 30.0K | 3.7M | 5.2M | 68.0K |
Pre-tax Income | -2.3M | 191.0K | -1.6M | 7.0M | -290.0K |
Income Tax | -5.0K | -7.0K | 107.0K | 63.0K | 296.0K |
Effective Tax Rate % | 0.0% | -3.7% | 0.0% | 0.9% | 0.0% |
Net Income | -1.5M | -1.8M | -2.0M | 6.9M | -1.1M |
Net Margin % | -4.7% | -5.2% | -4.9% | 16.9% | -2.4% |
Key Metrics | |||||
EBITDA | -455.0K | 2.1M | -6.8M | 3.0M | 1.1M |
EPS (Basic) | $-0.22 | $-0.26 | $-0.29 | $1.00 | $-0.16 |
EPS (Diluted) | $-0.22 | $-0.26 | $-0.29 | $0.99 | $-0.16 |
Basic Shares Outstanding | 7038000 | 7019000 | 6945000 | 6907000 | 6957000 |
Diluted Shares Outstanding | 7038000 | 7019000 | 6945000 | 6907000 | 6957000 |
Income Statement Trend
SunLink Health Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 7.2M | 4.5M | 6.8M | 10.0M | 11.2M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 3.4M | 2.6M | 4.6M | 4.2M | 4.3M |
Inventory | 1.6M | 1.6M | 1.7M | 1.9M | 1.9M |
Other Current Assets | 1.6M | 1.6M | 1.9M | 2.3M | 2.6M |
Total Current Assets | 15.7M | 12.3M | 16.8M | 21.9M | 19.9M |
Non-Current Assets | |||||
Property, Plant & Equipment | 516.0K | 798.0K | 17.1M | 15.2M | 14.8M |
Goodwill | 1.2M | 1.2M | 1.2M | 1.2M | 1.3M |
Intangible Assets | 1.2M | 1.2M | 1.2M | 1.2M | 1.3M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 443.0K | 6.3M | 523.0K | 591.0K | 500.0K |
Total Non-Current Assets | 4.9M | 11.0M | 11.1M | 9.6M | 8.0M |
Total Assets | 20.6M | 23.3M | 27.9M | 31.6M | 28.0M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 1.9M | 1.1M | 1.3M | 1.1M | 872.0K |
Short-term Debt | 331.0K | 334.0K | 392.0K | 3.4M | 1.8M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | 1.3M | - | - | 4.5M |
Total Current Liabilities | 4.2M | 4.9M | 7.7M | 9.7M | 11.4M |
Non-Current Liabilities | |||||
Long-term Debt | 197.0K | 481.0K | 871.0K | 927.0K | 2.6M |
Deferred Tax Liabilities | - | 69.0K | 69.0K | 0 | - |
Other Non-Current Liabilities | 229.0K | 309.0K | 192.0K | 162.0K | 248.0K |
Total Non-Current Liabilities | 426.0K | 982.0K | 1.1M | 1.1M | 2.8M |
Total Liabilities | 4.6M | 5.9M | 8.8M | 10.8M | 14.2M |
Equity | |||||
Common Stock | 3.5M | 3.5M | 3.5M | 3.5M | 3.4M |
Retained Earnings | 1.5M | 3.0M | 4.8M | 6.8M | -81.0K |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 16.0M | 17.4M | 19.1M | 20.8M | 13.7M |
Key Metrics | |||||
Total Debt | 528.0K | 815.0K | 1.3M | 4.3M | 4.3M |
Working Capital | 11.5M | 7.4M | 9.1M | 12.3M | 8.5M |
Balance Sheet Composition
SunLink Health Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -1.5M | -1.8M | -2.0M | 6.9M | -1.1M |
Depreciation & Amortization | 2.0M | 2.1M | 1.5M | 1.4M | 1.4M |
Stock-Based Compensation | - | - | - | 0 | 28.0K |
Working Capital Changes | -1.6M | -126.0K | 1.2M | -7.2M | 3.2M |
Operating Cash Flow | -1.2M | 129.0K | 850.0K | 811.0K | 3.6M |
Investing Activities | |||||
Capital Expenditures | 5.0K | 30.0K | 11.0K | 43.0K | 559.0K |
Acquisitions | 6.7M | 0 | - | - | 0 |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | 6.7M | 30.0K | 62.0K | 43.0K | 559.0K |
Financing Activities | |||||
Share Repurchases | - | - | - | 0 | -102.0K |
Dividends Paid | - | - | - | - | - |
Debt Issuance | - | - | - | 0 | 3.2M |
Debt Repayment | -14.0K | -40.0K | -36.0K | -35.0K | -3.0M |
Financing Cash Flow | -14.0K | -40.0K | -36.0K | -35.0K | 99.0K |
Free Cash Flow | -4.4M | -1.9M | -3.2M | -1.2M | 2.8M |
Net Change in Cash | 5.6M | 119.0K | 876.0K | 819.0K | 4.2M |
Cash Flow Trend
SunLink Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-5.07
Price to Book
0.59
Price to Sales
0.25
PEG Ratio
0.10
Profitability Ratios
Profit Margin
5.55%
Operating Margin
-9.33%
Return on Equity
-22.34%
Return on Assets
-13.62%
Financial Health
Current Ratio
3.92
Debt to Equity
4.98
Beta
1.15
Per Share Data
EPS (TTM)
$-0.39
Book Value per Share
$1.91
Revenue per Share
$4.42
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
ssy | 7.0M | -5.07 | 0.59 | -22.34% | 5.55% | 4.98 |
Walgreens Boots | 10.4B | 27.10 | 1.44 | -69.58% | -4.07% | 409.88 |
Wellgistics Health | 65.6M | -4.68 | 48.46 | -101.81% | -123.31% | 2,722.18 |
PetMed Express | 58.5M | 262.00 | 0.56 | 0.36% | 0.15% | 1.15 |
Scienture Holdings | 18.3M | 1.70 | 0.18 | -54.26% | 4.39% | 5.30 |
Hong Kong Pharma | 14.3M | 6.26 | 2.71 | -0.59% | -0.13% | 47.60 |
Financial data is updated regularly. All figures are in the company's reporting currency.